• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Aspen API. More than just an API™
    All News #Library
    Others

    Bayer Says it has cut 12,000 Jobs so far Under Restructuring Push

    REUTERS

    Wegovy maker Novo Nordisk to Reduce Costs After $95 billion stock

    REUTERS

    Report of Patient Deaths Sends Agios Shares Seesawing

    BIOSPACE

    Trump Ups the Ante on Pharma Tariffs, Saying Will Reach 250%

    CNBC

    FDA Approves Teva`s Ajovy for Migraine Prevention in Children

    REUTERS

    Alcon Agrees to Acquire STAAR Surgical

    BUSINESSWIRE

    Senate Bill Aims to keep NIH, CDC funds Intact

    FIERCE BIOTECH

    HilleVax Enter into a Definitive Agreement to be Acquired by XOMA

    GLOBENEWSWIRE

    AbbVie`s Rinvoq Produces Stellar Results in Alopecia Study

    FIERCE PHARMA

    US FDA names Sean Keveney as chief counsel

    REUTERS

    Vertex`s Trial Failure, Scrapped Study Cloud Pain Drug Push

    REUTERS

    Acadia Pharma Appoint Scott as Chief Information and Data Officer

    BUSINESSWIRE

    Astria Announces Inducement Grants Under Nasdaq LR 5635(c)(4)

    BUSINESSWIRE

    Exicure Regains Nasdaq Filing Compliance

    BUSINESSWIRE

    Regional Health And SunLink Win Shareholder Merger Nod

    BUSINESSWIRE

    CareEvolution Opens Remote Trial Signup For Long Covid

    BUSINESSWIRE

    Vertex Reports Ph2 Results Of VX-993 In Acute Pain

    BUSINESSWIRE

    Vertex Reports Second Quarter 2025 Financial Results

    BUSINESSWIRE

    Quanterix To Report Q2 Results On August 7, 2025

    BUSINESSWIRE

    Prothena Report Q2 Results And Business Highlights

    BUSINESSWIRE

    Hims & Hers Health Reports Second Quarter 2025 Financial Results

    BUSINESSWIRE

    AdaptHealth Corp. to Participate in Upcoming Investor Conference

    BUSINESSWIRE

    Lantern Launches AI Tool To Predict Blood-Brain Barrier Entry

    BUSINESSWIRE

    Quanterix Announces Cooperation Agreement with Kent Lake Capital

    BUSINESSWIRE

    Taconic & Cyagen Partner to Improve Preclinical Access

    BUSINESSWIRE

    Redwire Launches SpaceMD, Signs Deal with ExesaLibero

    BUSINESSWIRE

    Synchron Debuts Thought-Controlled iPad Experience

    BUSINESSWIRE

    Guardian Pharmacy Buys Oregon-Based Healthcare Firm

    BUSINESSWIRE

    Equillium Expands Crypto Treasury Reserve Strategy

    BUSINESSWIRE

    Alpha Cognition to Report Second Quarter 2025 Financial Results

    BUSINESSWIRE

    Niagen Bio to Present at Canaccord Genuity’s Growth Conference

    BUSINESSWIRE

    Precision Bio to Report Second Quarter 2025 Results on August 7

    BUSINESSWIRE

    Twist Bioscience Announces Fiscal 2025 Q3 Financial Results

    BUSINESSWIRE

    Clarametyx Biosciences Gets Fast Track, QIDP Tag for CMTX-101

    BUSINESSWIRE

    Lineage Doses First Patient in New OPC1 Spinal Injury Study

    BUSINESSWIRE

    enGene Reports Inducement Grants Under NASDAQ Rule 5635(c)(4)

    BUSINESSWIRE

    Marea Therapeutics Enrolls 1st Patient in Ph 2b TYDAL-TIMI Study

    BUSINESSWIRE

    Aatru Medical Clinical Study Published in PubMed/Cureus

    BUSINESSWIRE

    Number of Shares and Voting Rights of Innate Pharma

    BUSINESSWIRE

    IDEXX Laboratories Announces Second Quarter Results

    BUSINESSWIRE

    Tenpoint to Join Investor Conferences in August

    BUSINESSWIRE

    KalVista Pharma Reports Grants Under Nasdaq Rule 5635(c)(4)

    BUSINESSWIRE

    Bruker Reports Q2 2025 Financial Results

    BUSINESSWIRE

    Viridian Announces Grants Under Nasdaq Rule 5635(c)(4)

    BUSINESSWIRE

    Bayer Adds $1.37 Billion to Roundup Litigation Reserves

    REUTERS

    Poxel Changes Governance Post Reorganization Filing

    BUSINESSWIRE

    Sun Pharma Q1 Net Profit Down 20%, Revenue Up 9%

    BUSINESS STD

    Aurobindo to Acquire Lannett Company for Rs. 2,185 Cr

    INDPHARMAPOST

    Mounjaro measures up to Trulicity in Eli Lilly cardio trial

    FIERCE PHARMA

    Moderna Plans to Lay Off 10% of Workforce to Cut Costs

    REUTERS

    Xencor Adds Raymond Deshaies, Ph.D., to Director Board

    BUSINESSWIRE

    Tandem Diabetes Care to Participate in Upcoming Conference

    BUSINESSWIRE

    Guardant Health to Join Canaccord Genuity 45th Growth Conference

    BUSINESSWIRE

    Corcept Therapeutics Reveals Q2 Financial Results and Update

    BUSINESSWIRE

    Bio-Rad`s Q2 2025 Financial Results Released

    BUSINESSWIRE

    Enpro Announces Regular Quarterly Dividend

    BUSINESSWIRE

    Aptar`s Q2 2025 Results Released

    BUSINESSWIRE

    VB Spine Debuts in Australia and New Zealand

    BUSINESSWIRE

    Regenerex Pharma Inks Licensing Deal with Holista Colltech Ltd

    BUSINESSWIRE

    LucyRx Acquires CerpassRx to Boost Clinical Excellence

    BUSINESSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.